Literature DB >> 16172494

High complexity of Plasmodium vivax infections in Papua New Guinean children.

Jennifer L Cole-Tobian1, Moses Biasor, Christopher L King.   

Abstract

Although genetically distinct malaria parasites have been shown to simultaneously infect an individual, the total number of unique parasites has not been systematically studied. We examined multiple clones (8-38) from individual blood samples collected from Papua New Guinean children for polymorphisms in the Plasmodium vivax Duffy binding protein (dbpII) and the merozoite surface protein 3alpha (msp3alpha). We found a median of 4 (range = 2-6) and 12 (range = 2-23) unique genotypes based on dbpII and msp3alpha, respectively, per person at one time point and at least 12-33 unique genotypes per person over a four-month period. Control polymerase chain reactions (PCRs) detected 0-31% of clones with haplotypes that arose from PCR artifacts, indicating that caution must be taken when using PCR-based analysis to examine complex infections. To reduce artifacts from clones, analysis was based on haplotypes unlikely to have been generated by PCR artifacts or had been previously identified. Plasmodium vivax infections can be highly complex in disease-endemic areas, suggesting continual genetic mixing that could have significant implications for the use of antimalarial drugs and malaria vaccines.

Entities:  

Mesh:

Year:  2005        PMID: 16172494

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  9 in total

1.  Analysis of polymorphisms in the merozoite surface protein-3α gene and two microsatellite loci in Sri Lankan Plasmodium vivax: evidence of population substructure in Sri Lanka.

Authors:  Mette L Schousboe; Rupika S Rajakaruna; Priyanie H Amerasinghe; Flemming Konradsen; Rosalynn Ord; Richard Pearce; Ib C Bygbjerg; Cally Roper; Michael Alifrangis
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  High-throughput identification of the predominant malaria parasite clone in complex blood stage infections using a multi-SNP molecular haplotyping assay.

Authors:  Jennifer L Cole-Tobian; Peter A Zimmerman; Christopher L King
Journal:  Am J Trop Med Hyg       Date:  2007-01       Impact factor: 2.345

3.  Characterization and application of multiple genetic markers for Plasmodium malariae.

Authors:  M C Bruce; A Macheso; M R Galinski; J W Barnwell
Journal:  Parasitology       Date:  2006-12-04       Impact factor: 3.234

4.  On the evolution of reproductive restraint in malaria.

Authors:  Nicole Mideo; Troy Day
Journal:  Proc Biol Sci       Date:  2008-05-22       Impact factor: 5.349

5.  Worldwide genetic variability of the Duffy binding protein: insights into Plasmodium vivax vaccine development.

Authors:  Taís Nóbrega de Sousa; Luzia Helena Carvalho; Cristiana Ferreira Alves de Brito
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

6.  Diversity and evolutionary genetics of the three major Plasmodium vivax merozoite genes participating in reticulocyte invasion in southern Mexico.

Authors:  Lilia González-Cerón; Rene Cerritos; Jordán Corzo-Mancilla; Frida Santillán
Journal:  Parasit Vectors       Date:  2015-12-21       Impact factor: 3.876

7.  The Plasmodium vivax merozoite surface protein 3β sequence reveals contrasting parasite populations in southern and northwestern Thailand.

Authors:  Chaturong Putaporntip; Jun Miao; Napaporn Kuamsab; Jetsumon Sattabongkot; Jeeraphat Sirichaisinthop; Somchai Jongwutiwes; Liwang Cui
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

8.  Merozoite surface protein-3 alpha as a genetic marker for epidemiologic studies in Plasmodium vivax: a cautionary note.

Authors:  Benjamin L Rice; Mónica M Acosta; Maria Andreína Pacheco; Ananias A Escalante
Journal:  Malar J       Date:  2013-08-21       Impact factor: 2.979

9.  Genetic diversity of msp3alpha and msp1_b5 markers of Plasmodium vivax in French Guiana.

Authors:  Vincent Véron; Eric Legrand; Joséphine Yrinesi; Béatrice Volney; Stéphane Simon; Bernard Carme
Journal:  Malar J       Date:  2009-03-11       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.